Posted On: 10/15/2012 11:21:02 AM
Post# of 99178
ZLCS
NEW YORK, NY--(Marketwire - Oct 11, 2012) - The Biotechnology Industry has seen increased investor interest in 2012 as it continues to impress with strong gains. The iShares NASDAQ Biotechnology Index ETF (IBB) has gained over 35 percent this year, more than double the S&P 500 Index's gain of 15 percent. New legislation, increased mergers & acquisition activity as a result of major patent expirations have all been contributing factors to industry's rapid rise in 2012. Five Star Equities examines the outlook for companies in the Biotech Industry and provides equity research on Array Biopharma Inc. ( NASDAQ : ARRY ) and Zalicus Inc. ( NASDAQ : ZLCS ).
Access to the full company reports can be found at:
(0)
(0)
